© Reuters. Gilead earnings and revenue in the fourth quarter
Investing.com – Gilead (NASDAQ 🙂 reported on Thursday the fourth quarter that it beat analyst forecasts and revenue was above expectations. Gilead announced earnings per share of $ 2.19 on revenue of $ 7.33B. Analysts surveyed by Investing.com anticipated EPS of $ 2.01 on revenue of $ 7.03B. Gilead shares are up 13% since the beginning of the year, still 23.32% from their 52-week high of $ 85.90 set on March 19, 2020. They are outperforming Nasdaq, which is up 6, 9% from the beginning of the year. Gilead shares gained 1.72% in after-hours trading after the report. Gilead Follows Other Major Healthcare Gains This Month Gilead’s report follows an earnings hit from J&J on January 26, which reported EPS of $ 1.86 on revenue of $ 22.48B, compared to EPS forecasts of $ 1.82 on $ 21.66B revenue Roche Holding ADR had breached expectations on Monday with a fourth quarter EPS of $ 1.21 on $ 16.2B revenue, compared to the EPS forecast of $ 1.28 on $ 17.17B revenue. Stay up to date on all upcoming earnings reports by visiting the Investing.com earnings calendar.